Andrew G. Spencer
Keine laufenden Positionen mehr
Profil
Andrew G.
Spencer worked as a Senior VP-Preclinical Research & Development at Millendo Therapeutics, Inc. from 2016 to 2020.
Prior to that, he was a Vice President-Pharmacology at Ardelyx, Inc. Dr. Spencer holds a doctorate degree from Michigan State University and an undergraduate degree from Hope College.
Ehemalige bekannte Positionen von Andrew G. Spencer
| Unternehmen | Position | Ende |
|---|---|---|
| MILLENDO THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Ausbildung von Andrew G. Spencer
| Michigan State University | Doctorate Degree |
| Hope College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
